Cargando…

Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges

Ischemic stroke (IS) is a disease that is characterized by high mortality and disability. Recent studies have shown that LncRNA-mediated competing endogenous RNA (ceRNA) networks play roles in the occurrence and development of cerebral I/R injury by regulating different signaling pathways. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuxia, Zhu, Ting, Li, Qiaoyu, Sun, Guibo, Sun, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635732/
https://www.ncbi.nlm.nih.gov/pubmed/34867389
http://dx.doi.org/10.3389/fphar.2021.765075
_version_ 1784608388854841344
author Zhang, Shuxia
Zhu, Ting
Li, Qiaoyu
Sun, Guibo
Sun, Xiaobo
author_facet Zhang, Shuxia
Zhu, Ting
Li, Qiaoyu
Sun, Guibo
Sun, Xiaobo
author_sort Zhang, Shuxia
collection PubMed
description Ischemic stroke (IS) is a disease that is characterized by high mortality and disability. Recent studies have shown that LncRNA-mediated competing endogenous RNA (ceRNA) networks play roles in the occurrence and development of cerebral I/R injury by regulating different signaling pathways. However, no systematic analysis of ceRNA mechanisms in IS has been reported. In this review, we discuss molecular mechanisms of LncRNA-mediated ceRNA networks under I/R injury. The expression levels of LncRNAs, microRNAs (miRNAs), and messenger RNAs (mRNAs) and their effects in four major cell types of the neurovascular unit (NVU) are also involved. We further summarize studies of LncRNAs as biomarkers and therapeutic targets. Finally, we analyze the advantages and limitations of using LncRNAs as therapeutics for IS.
format Online
Article
Text
id pubmed-8635732
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86357322021-12-02 Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges Zhang, Shuxia Zhu, Ting Li, Qiaoyu Sun, Guibo Sun, Xiaobo Front Pharmacol Pharmacology Ischemic stroke (IS) is a disease that is characterized by high mortality and disability. Recent studies have shown that LncRNA-mediated competing endogenous RNA (ceRNA) networks play roles in the occurrence and development of cerebral I/R injury by regulating different signaling pathways. However, no systematic analysis of ceRNA mechanisms in IS has been reported. In this review, we discuss molecular mechanisms of LncRNA-mediated ceRNA networks under I/R injury. The expression levels of LncRNAs, microRNAs (miRNAs), and messenger RNAs (mRNAs) and their effects in four major cell types of the neurovascular unit (NVU) are also involved. We further summarize studies of LncRNAs as biomarkers and therapeutic targets. Finally, we analyze the advantages and limitations of using LncRNAs as therapeutics for IS. Frontiers Media S.A. 2021-11-17 /pmc/articles/PMC8635732/ /pubmed/34867389 http://dx.doi.org/10.3389/fphar.2021.765075 Text en Copyright © 2021 Zhang, Zhu, Li, Sun and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhang, Shuxia
Zhu, Ting
Li, Qiaoyu
Sun, Guibo
Sun, Xiaobo
Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
title Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
title_full Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
title_fullStr Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
title_full_unstemmed Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
title_short Long Non-Coding RNA-Mediated Competing Endogenous RNA Networks in Ischemic Stroke: Molecular Mechanisms, Therapeutic Implications, and Challenges
title_sort long non-coding rna-mediated competing endogenous rna networks in ischemic stroke: molecular mechanisms, therapeutic implications, and challenges
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635732/
https://www.ncbi.nlm.nih.gov/pubmed/34867389
http://dx.doi.org/10.3389/fphar.2021.765075
work_keys_str_mv AT zhangshuxia longnoncodingrnamediatedcompetingendogenousrnanetworksinischemicstrokemolecularmechanismstherapeuticimplicationsandchallenges
AT zhuting longnoncodingrnamediatedcompetingendogenousrnanetworksinischemicstrokemolecularmechanismstherapeuticimplicationsandchallenges
AT liqiaoyu longnoncodingrnamediatedcompetingendogenousrnanetworksinischemicstrokemolecularmechanismstherapeuticimplicationsandchallenges
AT sunguibo longnoncodingrnamediatedcompetingendogenousrnanetworksinischemicstrokemolecularmechanismstherapeuticimplicationsandchallenges
AT sunxiaobo longnoncodingrnamediatedcompetingendogenousrnanetworksinischemicstrokemolecularmechanismstherapeuticimplicationsandchallenges